Lipidomics
Early Stage
Lipids for treatment of inflammatory skin diseases, cosmetic and pharmaceutical products based on solid science.
Overview
Raised: $2,095
Total Commitments ($USD)
Platform
Netcapital
Start Date
06/22/2018
Close Date
10/01/2018
Min. Goal
$10,000
Max. Goal
$106,999
Min. Investment
$101
Security Type
Equity - Common
Funding Type
RegCF
Price Per Share
$1.94
Pre-Money Valuation
$2,801,443
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
09/30/2018
Days Remaining
Not Funded
% of Min. Goal
21%
% of Max. Goal
2%
Likelihood of Max
Not Funded
Avg. Daily Raise
$21
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Location
Corvallis, Oregon
Industry
Healthcare & Pharmaceuticals
Tech Sector
Lipidomics, Inc. is here with the solution for inflammatory skin diseases. They develop cosmetics and pharmaceutical products for dry and sensitive skin that help replenish liquids that are deficient in the skin barrier. Lipidomics scientific founders have been studying fundamental skin biology and dermatology for over two decades, and their studies have led them to create a topical application of two specific lipids that are effective for treating dry skin that can often be a precursor to eczema. Current treatments can suppress the immune response or have detrimental effects on skin health. Lipidomics’ product helps prevent that, allowing the integrity of the skin barrier to remain intact without triggering an immune response.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.